$6.95 0.05 (+0.72%)
11/27/2009 1:00 PM

POZEN, Inc. (POZN)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Featured Broker Partners